glp 1 brand names Radford Drug is adopting a new GLP-1 policy. GLP-1s, as well as many other brand-name drugs are unfairly controlled by both drug manufacturers and PBMs. These companies wish to squash local competitors 5 GLP-1 trends to expect
Description
One study found that semaglutide use was associated with a 50% reduction in risk of recurrent AUD diagnoses and a 56% reduced risk of AUD among individuals with type 2 diabetes

10.1089/thy.2024.0387

Syst Rev

Get More Every Week Subscribe to Nanalyze Weekly - our free, no-nonsense newsletter that delivers weekly article summaries, emerging tech insights, and clear analysis on disruptive tech companies - plus our bonus '7 Lessons From 20 Years of Disruptive Tech Investing' guide.

This led to further trials focused specifically on weight management
